@FierceMedDev: ICYMI: LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical. FierceDiagnostics Item | Follow @FierceMedDev
@VarunSaxena2: Four key medical device recalls of 2015. Feature | Follow @VarunSaxena2
@EmilyWFierce: Human Longevity joins with South African insurer for $250 exome sequencing service. FierceDiagnostics story | Follow @EmilyWFierce
> The Brits have signed off on the merger of Sorin and Cyberonics ($CYBX). It's all slated for the newly resulting LivaNova to be a done deal on Oct. 19. More
> Corvia Medical has gotten a second $17 million tranche to reach $34 million to back first transcatheter device designed to treat diastolic heart failure. SEC filing
> Xenios has raised an undisclosed, 8-figure sum in a financing led by ZFHN for its next-gen lung and heart support devices. More
Biotech News
@FierceBiotech: GlaxoSmithKline's asthma injection heads for EU approval. Story | Follow @FierceBiotech
@JohnCFierce: ICYMI: BIO boots Martin Shkreli's Turing out after pricing controversy erupts. Article | Follow @JohnCFierce
@DamianFierce: Hard to believe but the pope just described biotech valuations as "stretched." | Follow @DamianFierce
> Next-gen oncolytics upstart Replimune grabs a $30M transatlantic venture round. Report
> Concert Pharma's CF drug tops Vertex's top-seller in early study. Story
> GlaxoSmithKline's asthma injection heads for EU approval. Article
Pharma News
@FiercePharma: Mylan leverages marketing savvy, price hikes to make EpiPen a go-to med. More | Follow @FiercePharma
@EricPFierce: We all know about drug recalls but who tops the list for device recalls? FierceMedicalDevices feature | Follow @EricPFierce
> Novartis brings heart, cancer meds to low-income countries for $1 per month. More
> U.S. cancer drug prices up to 3X higher than in Europe: Study. Article
Vaccines News
> IDRI, Wellcome Trust to take tuberculosis jab to PhIIa in South Africa. Story
> Inovio-led team picks up $24M from DARPA to develop Ebola vaccine, treatments. Report
> Serum Institute sets out for dengue fast track. Article
> Scripps Florida nets 4-year, $6M grant from Gates Foundation for HIV vaccine. Story
> Advaxis reports 'encouraging' PhII cervical cancer vaccine data. More
CRO News
> U.K. CRO Venn buys up another contractor. Item
> ShangPharma plots a $60M splash for biologics R&D in China. Story
> German CRO cozies up to Bayer at its Berlin R&D hub. More
> Covance plots a deeper dive into manufacturing. Story
> BioClinica reaches into regulatory affairs with its latest buy. Article
Pharma Manufacturing News
> World's largest reinsurer ready to insure against FDA actions. Report
> Sun Pharma recalls more than 216,000 bottles after label leaches chemical. News
> Aesica plant to get power from biomass plant. More
> Mayne kicks off work on new $65M North Carolina plant. Story
> Pfizer finds buyer for Indian plant set to close this month. Article
Pharma Asia News
> Serum Institute of India throttles back on equity sale. Item
> China-focused RuiYi starts PhI in China on autoimmune candidate RYI-008. News
> HK-listed Lee's Pharmaceutical branches out further with Armetheon deal. More
> Japan's MHLW lines up about 50 candidates for fast-track 'sakigake' process. Story
> Australian subsidies for newer drugs go begging as companies avoid paper chase. Article